Since Leqembi was authorized within the U.S. in the summertime of 2023, controversy has roiled amongst clinicians over whether or not the Alzheimer’s anti-amyloid drug’s dangers…
The put up A 12 months Later, 5 Issues We’ve Realized From Sufferers on Leqembi appeared first on Being Affected person.
